This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Arimatsu Y, Hatamaka H (1986) Estrogen treatment enhances survival of cultured amygdala neurons in a defined medium. Dev Brain Res 26: 151–159
Armstrong RA (1995) Beta-amyloid deposition in the medial temporal lobe in elderly non-demented brains and in Alzheimer’s disease. Dementia 6: 121–125
Asthana S, Craft S et al. (1999) Cognitive and neuroendocrine response to trans-dermal estrogen in postmenopausal women with Alzheimer’s disease: results of a placebo controlled, double-blind, pilot study. Psychoneuroendocrinolgy 24: 657–677
Barret-Connor, Kritz-Silverstein D (1993) Estrogen replacement therapy and cognitive function in older women. JAMA 260: 2637–2641
Bartus RT, Dean RL, Beer B, Lippa AD (1981) The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 208–217
Birge SJ (1994) The role of estrogen deficiency in the aging of the central nervous system. In: Lobo RA (ed) Treatment of the postmenopausal woman: basic clinical aspects. Raven Press, New York, 153–157
Brenner DE, Kukull WA, Stergachis A, van Belle G, Bowen JD, McCormick WC, Teri L, Larson EB (1994) Postmenopausal estrogen replacement therapy and the risk of Alzheimer’s disease: a population-based case-control study. Am J Epidemiol 140: 262–267
Caldwell BM (1954) An evaluation of psychological effects of sex hormone administration in aged women. J Gerontol 9: 168–174
Caldwell BM, Watson RI (1952) An evaluation of psychologic effects of sex hormone administration in aged women. Results of therapy after 6 months. J Gerontol 7: 228–244
Campbell S, Whitehead M (1977) Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynecol 1: 31–47
Chakravorthy, Halbreich U (1997) Estrogen and platelet activity in postmenopausal women. Psychopharm Bull 33: 229–233
Chung SK, Pfaff DW, Cohen RS (1988) Estrogen-induced alterations in synaptic morphology in the midbrain central gray. Exp Brain Res 69: 522–530
Costa MM, Reus VI (1999) Estrogen replacement therapy and cognitive decline in memory impaired post-menopausal women. Biol Psychiatry 46: 182–188
Coyle JT, Price DL, DeLong MR (1983) Alzheimer’s disease: a disorder of cortical cholinergic innervation. Science 219: 1184–1190
Derby CA, Hume AL, McPhillips JB, Rarbour MM, Carleton RA (1995) Prior and current health characteristics of postmenopausal estrogen replacement therapy users compared with nonusers. Am J Obstet Gynecol 173: 544–550
Ditkoff EC, Crary WG, Cristo M, Lobo RA (1991) Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 78: 991–995
Faivre-Bauman A, Rosenbaum E, Puymirate J, Grouselle D, Tixier-Vidal A (1981) Differentiation of fetal mouse hypothalamic cells in a serum-free medium. Dev Neurosci 4: 118–129
Fedor-Freybergh P (1977) The Influence of oestrogens on the wellbeing and mental performance in climacteric and postmenopausal women. Acta Obstet Gynecol Scand 3: 64–69
Fillit H, Weinreb H, Cholst I (1986) Observations in a preliminary open trial of estradiol therapy for senile dementia (Alzheimer’s type). Psychoneuroendocrinology 11: 337–345
Hackman R., Galbraith D (1976) Replacement therapy with piperazine oestrone sulfate and its effect on memory. Curr Med Res Opin 4: 303–306
Halbreich U (1995) Estrogen as a potential psychotropic medication. Presented at the 26th Congress of the International Society of Psychoneuroendocrinology, September, Munich, Germany
Halbreich U (1995) Menstrually related disorders: What we do know, what we only believe we know, and what we know that we do not know. Crit Rev Neurobiol 2/3: 163–175
Halbreich U (1997) Role of estrogen in postmenopausal depression. Neurology 48(Suppl 7): 16–20
Halbreich U, Piletz JE, Carson S, Halaris A, and Rojansky N (1993) Increased imidazoline and alpha-2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes. Biol Psychiatry 34: 676–686
Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K (1995) Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 37: 434–441
Hampson E, Kimura D (1988) Reciprocal effects of hormonal fluctuations on human motor and perceptual-spatial skills. Behav Neurosci 102: 456–459
Hefti F, Knusel B, Lapchak PA (1993) Protective effects of nerve growth factor and brain derived neurotrophic factor on basal forebrain cholinergic neurons in adult rats with partial fimbrial transections. Progr Brain Res 98: 257–263
Hemminki E, Malin M, Topo P (1993) Selection to postmenopausal therapy by women’s characteristics. J Clin Epiderniol 46: 211–219
Henderson VW (1997) The epidemiology of estrogen replacement therapy and Alzheimers disease. Neurology 48(Suppl 7): 27–35
Henderson YW, Paganini-Hill A, Emmanuel CK, Dunn ME, Buckwalter JG (1994) Estrogen replacement therapy in older women. Comparisons between Alzheimers disease cases and non-demented control subjects. Arch Neurol 51: 896–900
Hogervorst E, Boshuisen M, Riedel W, Willeken C, Jolles J (1999) The effect of hormone replacement therapy on cognitive function in elderly women. Psychoneuroendocrinology 24: 43–68
Honjo H, Ogino Y, Naitoh K (1989) In vivo effects by estrone sulfate on the central nervous system: Senile dementia (Alzheimer’s type). J Steroid Biochem Mol Biol 34: 521–525
Jarvik LF (1975) Human intelligence: sex differences. Acta Genet Med Gemellol (Rome) 24: 189–211
Jorm AF, Korten AE, Henderson AS (1987) The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 76: 465–479
Kahn L, Halbreich U (1999) Menopause and psychopharmacology: signs, symptoms, and treatment. In: Crosignani PG, Kenemans K, Wenger NK, Jackson AS (eds) Women’s Health and Menopause: Risk Reduction Strategies — Improved Quality of Health. Kluwer Academic Publishers, Boston, 131–136
Kampen D, Sherwin B (1994) Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol 83: 979–83
Kantor HI, Michael CM, Shore H (1973) Estrogen for older women. Am J Obstet Gynaecol 116: 115–118
Kawata M (1995) Roles of steroid hormones and their receptors in structural organization in the central nervous system. Neurosci Res 24: 1–46
Kendall DA, Stancel GM, Enna SJ (1981) Imipramine: effect of ovarian steroids on modifications in serotonin receptor binding. Science 211: 1183–1185
Lerner A, Cole R, Debanne S (1995) Immunological and endocrine conditions in an Alzheimer’s disease case-control study (abstract). Neuroepidemiology 14: 307
McEwen BS, Alves SE, Bulloch K, Weiland NG (1997) Ovarian steroids and the brain: implications for cognition and aging. Neurology 48(Suppl 7): S8–S15
McEwen BS, Woolley CS (1994) Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp Gerontol 29: 431–436
Mendelsohn ME, Karas RH (1999) The protective effects of estrogen on the cardiovascular system. N Engl J Med 340: 1801–1811
Morrison A, Resnik S, Corrada M, Zonderman A, Kawas C (1996) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer’s disease in the Baltimore longitudinal study of aging (abstract). Neurology 46(Suppl 2): 435–436
Mortel KF, Meyer JS (1995) Lack of postmenopausal estrogen replacement therapy and risk of dementia. J Neuropsychiatr Clin Neurosci 7: 334–337
Nass R, Raker S (1991) Androgen effects on cognition: congenital adrenal hyperplasia. Psychoendocrinology 16: 189–201
Nee LE, Eldrige R, Sunderland T, Thomas CB, Katz D, Thompson KE, Weingartner H, Weiss H, Julian C, Cohen R (1987) Dementia of the Alzheimer type: clinical and family study of 22 twin pairs. Neurology 37: 359–363
Ohkura T, Teshima Y, Isse K, et al (1994) Estrogen increases cerebral and cerebellar blood flows in postmenopausal. Menopause 2: 13–18
Okhura T, Isse K, Akazawa K (1995) Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer’s type: 7 case reports. Dementia 6: 99–107
Paganini-Hill A, Henderson VW (1994) Estrogen deficiency and risk of Alzheimer’s disease in women. Am J Epidemiol 140: 256–261
Paganini-Hill A, Henderson YW (1996) Estrogen replacement therapy and risk of Alzheimer’s disease. Arch Intern Med 156: 2213–2217
Pericak-Vance MA, Haines JL (1995) Genetic susceptibility to Alzheimer’s disease. Trends Genet 11: 504–508
Perlman S (1973) Cognitive abilities of children with hormone abnormalities: screening by psychoeducational tests. J Learn Disabil 6: 24–34
Phillips SM, Sherwin ER (1992) Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17: 485–495
Polderman KR, Sthouwer CD, van Kamp GJ, Schalkwijk CG, Gooren LJ (1993) Influence of sex hormones on plasma endothelin levels. Ann Intern Med 118: 429–432
Rarrett-Connor, E and Goodman-Gruen (1999) Cognitive function and endogenous sex hormones in older women. J Am Geriatr Soc 11: 1289–1293
Regland B, Gottfries CG (1992) The role of amyloid beta-protein in Alzheimer’s disease. Lancet 340: 467–469
Resnik S, Berenbaum S, Gottesman T, Bouchard T (1986) Early hormonal influences on cognitive functioning in congenital adrenal hypreplasia. Dev Psychol 22: 191–198
Rirge SJ (1997) The role of estrogen in the treatment of Alzheimer’s disease. Neurology 48(Suppl 7): 36–41
Rosencrans JA (1970) Differences in brain area 5-hydroxytryptamine turnover and rearing behavior in rats and mice of both sexes. Eur J Pharmacol 9: 379–382
Sar M, Stumpf WE (1981) Central noradrenergic neurones concentrate 3H-oestradiol. Nature 289: 500–502
Schneider LS, Farlow MR, Henderson VW, Pogoda JM (1996) Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer’s disease. Neurology 46: 1580–1584
Shaywitz SE, Shaywitz BA, Pugh KR et al. (1999) Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 281: 1197–1202
Sherwin BB (1997) Estrogen effects on cognition in menopausal women. Neurology 48(Suppl 7): 21–26
Sherwin BB, Phillips S (1990) Estrogen and cognitive functioning in surgically menopausal women. Ann NY Acad Sci 592: 474–475
Sherwin BR, Tulandi T (1996) "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab 81: 2545–2549
Sherwin ER (1994) Estrogenic effects on memory in women. Ann NY Acad Sci 743: 213–231
Shugrue PJ, Dorsa DM (1993) Estrogen modulates the growth-associated protein GAP-43 (neuromodulin) mRNA in the rat preoptic area and basal hypothalamus. Neuroendocrinology 57: 439–447
Singh M, Meyer EM, Millard WJ, Sirnpkins JW (1994) Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res 644: 305–312
Small GW, Leuchter AF, Mandelkern MA, La Rue A, Okonek A, Lufkin RB, Jarvik LF, Matsuyama SS, Bondareff W (1993) Clinical, neuroimaging, and environmental risk differences in monozygotic female twins appearing discordant for dementia of the Alzheimer type. Arch of Neurol 50: 209–219
Sorabji F, Miranda RC, Toran-Allerand CD (1994) Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J Neurosci 14: 459–471
Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayenx R (1996) Effect of estrogen during menopause on risk and age at onset of Alzheime’s disease. Lancet 348: 429–432
Terasawa E, Timiras P (1968) Electrical activity during the estrous cycle of the rat: cyclic changes in limbic structures. Endocrinology 83: 207–216
Toran-Allerand CD (1984) On the genesis of sexual differentiation of the central nervous system: morphogenic consequences of steroidal exposure and possible role of a fetoprotein. Progr Brain Res 61: 63–98
Toran-Allerand CD (1993) Orgnotypic culture of the developing cerebral cortex and hypothalamus: relevance to sexual differentiation. Psychoneuroendocrinology 57: 439–447
Toran-Allerand CD, Miranda RC, Bentharn WD, Sohrabji F, Brown TJ, Hochberg RB, MacLusky NJ (1992) Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA 89: 4668–4672
Van Buren G, Yang D, Clark KE (1992) Estrogen-induced uterine vasodilation isantogonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol 167: 828–833
Van Duijn CM, Hofman A (1992) Risk factors for Alzheimer’s disease: the EURODEM collaborative re-analysis of case-control studies. Neuroepidemiology 11(Suppl 1): 106–113
Warren SG, Humphreys AG, Juraska JM, Greenough WT (1995) LTP varies across the estrous cycle: enhanced synaptic plasticity in proestrus rats. Brain Res 703: 26–30
Wong M, Moss RL (1992) Long-term and short-term electrophysiological effects of estrogen on the synaptic properties hippocampal CA1 neurons. J Neurosci 12: 3217–3225
Woolley CS, McEwen BS (1993) Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol 57: 935–939
Wu X, Glinn MA, Ostrowski NL, Su Y, Ni B, Cole HW, Bryant HN, Paul SM (1999) Raloxifene and estradiol benzoate both fully restore hippocampal choline acetyl-transferase activity in ovarectomized rats. Brain Res 847: 98–104
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag/Wien
About this chapter
Cite this chapter
Edwin, T., Halbreich, U. (2005). The Effects of Estrogens on Cognition and Alzheimer's Dementia. In: Bergemann, N., Riecher-Rössler, A. (eds) Estrogen Effects in Psychiatric Disorders. Springer, Vienna. https://doi.org/10.1007/3-211-27063-9_11
Download citation
DOI: https://doi.org/10.1007/3-211-27063-9_11
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-40485-0
Online ISBN: 978-3-211-27063-9
eBook Packages: MedicineMedicine (R0)